Normal body mass index (BMI) can rule out metabolic syndrome: An Israeli cohort study.


Journal

Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R

Informations de publication

Date de publication:
03 2019
Historique:
entrez: 1 3 2019
pubmed: 1 3 2019
medline: 15 3 2019
Statut: ppublish

Résumé

The aim of the study was to assess whether body mass index (BMI) can be used as a simple and reliable survey test for metabolic syndrome.The study is an observational cohort study among patients who visited the Rambam Periodic Examinations Institute (RPEI). We analyzed the correlation between obesity indices and presence of metabolic syndrome. We identified the ideal value of BMI for identification of patients at risk for metabolic syndrome. We also described the correlation between different BMI values and its negative predictive value (NPV) for metabolic syndrome.During the study years, 23,993 patients visited the RPEI, and 12.5% of them fulfilled the criteria for metabolic syndrome. Women with metabolic syndrome had higher proportion of obesity, when compared with men (89.9% vs 52.6%; P < .0001). Normal BMI had very high NPV to rule out metabolic syndrome among men and women (98% and 96%, respectively). Using receiver-operating characteristic curve, we found BMI 27 to be the ideal value for identification of metabolic syndrome for the entire cohort (area under the curve [AUC] 0.767, 95% confidence interval [CI] 0.758-0.775, P < .0001), for men (AUC 0.726, 95% CI 0.715-0.738, P < .0001), and for women (AUC 0.843, 95% CI 0.831-0.855, P < .0001). BMI below 30 provided NPV of 91.1% to rule out metabolic syndrome.The BMI as single survey measurement of obesity offers high NPV for metabolic syndrome and can be used by physician and patients for this purpose.

Identifiants

pubmed: 30817613
doi: 10.1097/MD.0000000000014712
pii: 00005792-201903010-00053
pmc: PMC6831180
doi:

Substances chimiques

Lipids 0

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e14712

Commentaires et corrections

Type : ErratumIn

Références

Diabetes Metab Syndr Obes. 2013 Oct 24;6:403-19
pubmed: 24179379
Circulation. 2004 Sep 7;110(10):1245-50
pubmed: 15326067
Eur J Intern Med. 2016 Oct;34:89-93
pubmed: 27545645
Fam Pract. 2009 Oct;26(5):365-71
pubmed: 19589884
Endocr Pract. 2003 May-Jun;9(3):237-52
pubmed: 12924350
JAMA. 2015 May 19;313(19):1973-4
pubmed: 25988468
Rev Esp Cardiol (Engl Ed). 2012 Mar;65(3):241-8
pubmed: 22305818
J Pediatr Endocrinol Metab. 2018 Jul 26;31(7):717-725
pubmed: 29794252
Diabetol Metab Syndr. 2010 May 12;2(1):28
pubmed: 20459858
Diabetes Metab Syndr Obes. 2014 Jul 31;7:341-6
pubmed: 25114576
Diabetes Care. 2005 Apr;28(4):882-7
pubmed: 15793190
Bioinformation. 2012;8(13):613-6
pubmed: 22829741
Eur J Cardiovasc Prev Rehabil. 2011 Aug;18(4):561-73
pubmed: 21450629
Circulation. 2002 Dec 17;106(25):3143-421
pubmed: 12485966
J Paediatr Child Health. 2014 Jul;50(7):519-24
pubmed: 24909833
Int J Cardiol. 2007 Apr 25;117(2):204-10
pubmed: 16854482
Sci Rep. 2018 Mar 6;8(1):4088
pubmed: 29511278
Int J Environ Res Public Health. 2018 Jul 13;15(7):
pubmed: 30011785
Obesity (Silver Spring). 2011 May;19(5):1083-9
pubmed: 21372804
Obesity (Silver Spring). 2009 Sep;17(9):1789-95
pubmed: 19343017
PLoS Med. 2012;9(6):e1001230
pubmed: 22679397
PLoS One. 2015 Apr 16;10(4):e0122985
pubmed: 25880905
Eur J Prev Cardiol. 2015 Apr;22(4):486-91
pubmed: 24647805
Metab Syndr Relat Disord. 2009 Oct;7(5):427-34
pubmed: 19754305
Diabetes. 2003 May;52(5):1210-4
pubmed: 12716754

Auteurs

Ofer Kobo (O)

Department of Cardiology, Hillel Yaffe Hospital.

Ronit Leiba (R)

The Epidemiology Institute.

Ophir Avizohar (O)

The Periodic Examinations Institute.

Amir Karban (A)

Department of Internal Medical, Rambam Healthcare Campus, Haifa, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH